Intelligent Design Control – Risk Management
Next-Generation Design Control: Watch the third webinar of this three-part series on Intelligent Design Control – Risk Management that addresses post-market surveillance activities.
Calculation of residual risk, process controls and integration of FMEAS, ISO 14971, and post market surveillance activities.
The last of our 3-part series on Intelligent Design Control.
About our Intelligent Design Control Series
Medical device companies struggle to build ISO 14971 compliant hierarchical risk structures which include harms analysis and levels of FMEA contribution. Our Intelligent Design Control thread uncovers how proper construction satisfies these regulatory challenges and contributes to the product definition and integration with systems engineering methods.
About our Master Class Host
With 20-years of operational experience in Medical Device, Larry Sampson knows first-hand how to balance device development agility and regulatory considerations.
As a Sr. Director of Medical Device Processes at Siemens, Larry spends his days educating medical device manufacturers on best practices in all aspects of their product lifecycles. Outside the 9-5, Larry enjoys the great outdoors of Colorado with his family.